| View |
|
DR-XY44990
|
Articaine Hydrochloride + Epinephrine (as bitartrate)
|
Posicaine 100
|
40 mg/10 mcg per mL
|
Solution For Injection (Oromucosal)
|
-
|
Novocol Pharmaceutical of Canada Inc.
|
Canada
|
-
|
25 March 2022
|
13 January 2026
|
| View |
|
DR-XY44991
|
Rabeprazole Sodium
|
Korab 20
|
20 mg
|
Enteric-coated tablet
|
-
|
Kopran Limited
|
India
|
-
|
26 November 2020
|
12 January 2026
|
| View |
|
DR-XY44992
|
Ascorbic Acid
|
Epica-Cee
|
500mg ( eq. to 562.50 mg sodIUm ascorbate)
|
Capsule
|
-
|
Novagen Pharmaceutical Co., Ltd.
|
Philippines
|
-
|
21 December 2020
|
18 January 2026
|
| View |
|
DR-XY44996
|
Flumazenil
|
Ansed
|
100 mcg/ mL
|
Solution For Injection (Iv)
|
-
|
Baxter Pharmaceuticals India Private Limited
|
India
|
-
|
08 January 2021
|
20 January 2026
|
| View |
|
DR-XY44997
|
Cefixime (as trihydrate)
|
Macxime
|
200 mg/5mL
|
Powder for Suspension
|
Antibacterial
|
Mc Olson Research Laboratories (Pvt) Ltd.
|
Pakistan
|
Automatic Renewal
|
19 August 2021
|
20 January 2026
|
| View |
DR-XY44998_PI_01.pdf
|
DR-XY44998
|
Dabrafenib (As Mesilate)
|
Tafinlar
|
75 mg
|
Capsule
|
-
|
Glaxo Operations UK Limited Trading as Glaxo
Wellcome Operations
|
United Kingdom
|
Initial (from Monitored release)
|
02 December 2022
|
02 February 2026
|
| View |
DR-XY44999_PI_01.pdf
|
DR-XY44999
|
Dabrafenib (As Mesilate)
|
Tafinlar
|
50 mg
|
Capsule
|
-
|
Glaxo Operations UK Limited Trading as Glaxo Wellcome Operations
|
United Kingdom
|
Initial (from Monitored release)
|
02 December 2022
|
02 February 2026
|
| View |
|
DR-XY45003
|
Omeprazole
|
Miracid
|
20mg
|
Delayed-Release Capsule
|
-
|
Berlin Pharmaceutical Industry Co., Ltd.
|
Thailand
|
-
|
12 April 2021
|
22 January 2026
|
| View |
|
DR-XY45004
|
Tranexamic Acid
|
Cycloxid
|
100mg/mL
|
Solution For Injection (Iv)
|
-
|
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
|
China
|
-
|
10 February 2021
|
22 January 2026
|
| View |
|
DR-XY45005
|
Phosphatidyl Choline + Multivitamins
|
Hepamed
|
Formulation Each Soft Gel Capsule contains: Phosphatidyl Choline-300 mg Thiamine Mononitrate (Vitamin B1)-6 mg Riboflavin (Vitamin B2)-6 mg Pyridoxine (Vitamin B6)-6 mg Nicotinamide (Vitamin B3)-30 mg Cyanocobalamin (Vitamin B12)-60 mcg dl-alpha-Tocopherol Acetate (Vitamin E)- 6 mg (equivalent to 6 IU)
|
Soft Gel Capsule
|
-
|
Northfield Laboratories, Inc.
|
Philippines
|
-
|
02 March 2021
|
02 February 2026
|
| View |
|
DR-XY45006
|
Phosphatidyl Choline + Vitamin B-Complex + Vitamin E
|
Essenphos
|
300mg/6mg/6mg/6mg/30mg/6mcg/6mg
|
Softgel Capsule
|
-
|
Northfield Laboratories, Inc.
|
Philippines
|
-
|
17 February 2021
|
22 January 2026
|
| View |
|
DR-XY45007
|
Phosphatidyl Choline + Multivitamins
|
Essenvit Forte
|
Formulation: Each Softgel capsule contains: Phosphatidyl Choline-300 mg Thiamine Mononitrate (Vitamin B1) -6 mg Riboflavin (Vitamin B2)-6 mg Nicotinamide (Vitamin B3)- 30 mg Pyridoxine Hydrochloride (Vitamin B6)-6 mg Cyanocobalamin (Vitamin B12)-6 mcg dl-alpha Tocopheryl Acetate (Vitamin E)
-6 mg (equivalent to 6 IU)
|
Softgel Capsule
|
-
|
Northfield Laboratories Inc.
|
Philippines
|
-
|
04 March 2021
|
22 January 2026
|
| View |
|
DR-XY45008
|
Atracurium Besilate
|
Kabitran
|
10 mg/mL (25 mg/2.5mL)
|
Solution For Injection (Iv)
|
-
|
Gland Pharma Limited
|
India
|
-
|
08 February 2021
|
28 January 2026
|
| View |
|
DR-XY45014
|
D-Alpha Tocopherol (Vitamin E)
|
None
|
400 IU
|
Softgel Capsule
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
01 December 2020
|
26 January 2026
|
| View |
|
DR-XY45016
|
Thiamine Nitrate (Vitamin B1) + Pyridoxine Hydrochloride
(Vitamin B6) + Mecobalamin (Vitamin B12) + Folic Acid
|
Foliage Max
|
200 mg/50 mg/500 mcg/5 mg
|
Capsule
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
24 February 2021
|
29 January 2026
|
| View |
|
DR-XY45017
|
Trimetazidine Hydrochloride
|
Angirel MR
|
35 mg
|
Modified-Release Tablet
|
-
|
Unison Laboratories Co., Ltd.
|
Thailand
|
-
|
31 March 2021
|
22 February 2026
|
| View |
|
DR-XY45019
|
Desonide
|
Dosetil
|
0.5 mg/g (0.05 % w/w)
|
Cream
|
Topical Corticosteroid
|
Glenmark Pharmaceuticals Ltd. (Unit II)
|
India
|
Automatic Renewal
|
02 December 2020
|
29 January 2026
|
| View |
|
DR-XY45020
|
Lansoprazole
|
Lanozol
|
30 mg
|
Delayed-Release Capsule
|
-
|
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
|
China
|
-
|
28 January 2016
|
28 January 2026
|
| View |
|
DR-XY45021
|
Febuxostat
|
Urica
|
80mg
|
Film-Coated Tablet
|
-
|
Advanced Chemical Industries (ACI) Ltd.
|
Bangladesh
|
Initial [from Monitored Release]
|
30 May 2022
|
29 January 2026
|
| View |
|
DR-XY45022
|
Ondansetron (as hydrochloride dehydrate)
|
Ondavell
|
8 mg
|
Film Coated Tablet
|
Antiemetic (5-HT3 Antagonist)
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
11 March 2022
|
02 February 2026
|